Pharmaron Beijing Co Ltd Asset Resilience Ratio

Latest as of September 2025: 4.17%

Pharmaron Beijing Co Ltd asset resilience ratio. Pharmaron Beijing Co Ltd (300759) has an Asset Resilience Ratio of 4.17% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Pharmaron Beijing Co Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.08 Billion

≈ $157.33 Million USD Cash + Short-term Investments

Total Assets

CN¥25.80 Billion

≈ $3.78 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Pharmaron Beijing Co Ltd (2018–2024)

Asset resilience ratio of Pharmaron Beijing Co Ltd from 2018 to 2024. This chart shows how Pharmaron Beijing Co Ltd's Asset Resilience Ratio has changed over time. See Pharmaron Beijing Co Ltd (300759) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Pharmaron Beijing Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 300759 asset base.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.08 Billion	4.17%
Total Liquid Assets	CN¥1.08 Billion	4.17%

Asset Resilience Insights

Limited Liquidity: Pharmaron Beijing Co Ltd maintains only 4.17% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Pharmaron Beijing Co Ltd Industry Peers by Asset Resilience Ratio

Compare Pharmaron Beijing Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai Medicilon Inc SHG:688202	Biotechnology	6.69%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.76%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%

Pharmaron Beijing Co Ltd Asset Resilience Ratio by Year (2018–2024)

Pharmaron Beijing Co Ltd asset resilience ratio by year from 2018 to 2024. The table below shows the annual Asset Resilience Ratio data for Pharmaron Beijing Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	4.66%	CN¥1.12 Billion ≈ $163.20 Million	CN¥23.93 Billion ≈ $3.50 Billion	+2.42pp
2023-12-31	2.24%	CN¥594.33 Million ≈ $86.97 Million	CN¥26.48 Billion ≈ $3.87 Billion	-1.39pp
2022-12-31	3.64%	CN¥745.36 Million ≈ $109.07 Million	CN¥20.49 Billion ≈ $3.00 Billion	-4.82pp
2021-12-31	8.45%	CN¥1.55 Billion ≈ $227.49 Million	CN¥18.39 Billion ≈ $2.69 Billion	+0.81pp
2020-12-31	7.64%	CN¥910.01 Million ≈ $133.16 Million	CN¥11.91 Billion ≈ $1.74 Billion	+5.79pp
2019-12-31	1.85%	CN¥183.45 Million ≈ $26.84 Million	CN¥9.94 Billion ≈ $1.45 Billion	+1.84pp
2018-12-31	0.01%	CN¥412.62K ≈ $60.38K	CN¥4.63 Billion ≈ $676.85 Million	--

pp = percentage points

About Pharmaron Beijing Co Ltd

SHE:300759 China Biotechnology

Market Cap

$8.94 Billion

CN¥61.09 Billion CNY

Market Cap Rank

#2347 Global

#227 in China

Share Price

CN¥41.37

Change (1 day)

+3.42%

52-Week Range

CN¥21.72 - CN¥51.15

All Time High

CN¥10080.27